SOM Share Price Performance
AU$0.84
0.47 (127.03%)
Price AU$0.84
Share PriceAU$0.84
SomnoMed Limited's (ASX:SOM) 29% Dip In Price Shows Sentiment Is Matching Revenues
Apr 25
SomnoMed Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
SOM Community Narratives
There are no narratives available yet.
SomnoMed Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.016
- Gross Margin
- 59.85%
- Net Profit Margin
- -3.10%
- Debt/Equity Ratio
- 1.7%
SomnoMed Limited Competitors
Snowflake Analysis
About SOM
- Founded
- 1987
- Employees
- n/a
- CEO
- WebsiteView website
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Australian Market Performance
- 7 Days: 0.4%
- 3 Months: 5.4%
- 1 Year: 8.9%
- Year to Date: 9.7%
In the last week, the market has stayed flat, however the Materials sector stood out, gaining 3.8%. As for the longer term, the market has risen 8.9% in the past 12 months. Looking forward, earnings are forecast to grow by 12% annually. Market details ›